middl
east
respiratori
syndrom
coronaviru
merscov
dipeptidyl
peptidas
solubl
antivir
therapi
b
r
c
dipeptidyl
peptidas
receptor
merscov
solubl
form
circul
systemat
competit
inhibit
merscov
entri
host
cell
measur
concentr
plasma
sputa
merscovinfect
patient
variou
degre
diseas
sever
concentr
plasma
mer
patient
ngml
significantli
lower
healthi
control
ngml
signific
differ
among
patient
group
interestingli
plasma
level
egf
neg
posit
correl
concentr
respect
level
sputa
less
ngml
viral
infect
inhibit
presenc
ngml
therefor
level
plasma
mer
patient
significantli
reduc
threshold
need
exert
antivir
effect
merscov
infect
middl
east
respiratori
syndrom
coronaviru
merscov
emerg
zoonot
pathogen
caus
sever
respiratori
diseas
mortal
rate
approxim
sinc
first
isol
total
mer
case
confirm
relat
death
report
septemb
countri
de
wit
et
al
organ
largest
outbreak
mer
outsid
arabian
peninsula
occur
republ
korea
result
confirm
case
death
kim
et
al
despit
high
mortal
proper
antivir
therapi
establish
yet
dipeptidyl
peptidas
identifi
function
receptor
merscov
interact
spike
protein
raj
et
al
notabl
cleav
membran
releas
circul
solubl
form
although
physiolog
role
poorli
understood
level
plasma
vari
depend
pathophysiolog
condit
presenc
metabol
diseas
inflamm
lambeir
et
al
rohrborn
et
al
level
enzym
activ
also
affect
viral
infect
includ
hepat
c
viru
epsteinbarr
viru
andrieu
et
al
sinc
capabl
interf
merscov
infect
competit
interact
viral
spike
protein
raj
et
al
sought
evalu
level
bodi
fluid
mer
patient
clinic
specimen
mer
patient
collect
hospit
chungnam
nation
univers
hospit
describ
previou
studi
studi
perform
follow
approv
institut
review
board
chungnam
nation
univers
hospit
seoul
nation
univers
hospit
irb
number
cnuh
surviv
patient
healthi
volunt
provid
written
inform
consent
particip
fatal
case
obtain
exempt
patient
consent
institut
review
board
retrospect
analysi
clinic
sampl
inform
clinic
immunolog
respons
mer
patient
denot
identifi
avail
previou
report
basic
inform
patient
clinic
specimen
also
summar
supplementari
tabl
expector
sputa
sampl
process
analyz
level
previous
describ
willi
et
al
brief
sputum
dilut
phosphatebuff
salin
pb
mechan
disrupt
use
needl
centrifug
separ
cellular
materi
plasma
sputum
sampl
dilut
pb
measur
use
human
quantikin
elisa
kit
r
system
minneapoli
mn
usa
accord
manufactur
instruct
spikepseudotyp
lentiviru
prepar
describ
previou
studi
pseudovirus
preincub
serial
dilut
r
system
minneapoli
mn
usa
h
subsequ
atcc
manassa
va
usa
cell
express
human
infect
incub
h
previous
describ
viru
entri
quantifi
luciferas
assay
use
luciferas
assay
kit
promega
madison
wi
usa
accord
manufactur
instruct
plaqueform
assay
merscov
moi
well
provid
korean
center
diseas
control
yang
et
al
preincub
ad
vero
cell
cultur
h
incub
cell
overlaid
medium
contain
seaplaqu
agaros
lonza
basel
switzerland
h
merscov
infect
cell
fix
stain
antim
cov
n
protein
antibodi
sino
biolog
inc
beij
china
count
viral
plaqu
korean
outbreak
collect
blood
respiratori
secret
sampl
mer
patient
wide
rang
clinic
sever
mild
febril
ill
fatal
pneumonia
patient
classifi
four
group
base
diseas
sever
previous
describ
briefli
group
n
includ
patient
mild
febril
ill
recov
without
treatment
group
ii
n
compris
patient
develop
mild
pneumonia
without
hypoxemia
group
iii
n
group
iv
n
includ
infecti
case
result
sever
pneumonia
fatal
respect
detail
clinic
characterist
immunolog
respons
previous
describ
measur
concentr
protein
plasma
sputa
patient
healthi
control
elisa
level
plasma
mer
patient
ngml
significantli
lower
healthi
control
ng
ml
fig
left
panel
level
rel
variabl
significantli
associ
age
gender
normal
control
supplementari
tabl
knowledg
first
report
demonstr
decreas
protein
level
patient
experienc
acut
viral
infect
mer
patient
group
display
statist
signific
decreas
plasma
level
compar
healthi
control
fig
right
panel
although
sampl
group
iv
fatal
case
show
lowest
valu
ng
ml
statist
signific
differ
among
patient
group
level
sputa
sampl
ngml
much
lower
compar
plasma
sampl
signific
differ
among
patient
group
fig
kinet
chang
level
plasma
sputa
show
person
variat
without
notabl
trend
acut
phase
infect
supplementari
tabl
could
found
correl
level
diseas
sever
given
capabl
suppress
merscov
infect
act
decoy
receptor
assess
abil
suppress
entri
merscov
percent
inhibit
viral
entri
ngml
approxim
respect
fig
concentr
higher
ngml
requir
achiev
inhibit
pseudotyp
lentiviru
infect
indic
physiolog
level
plasma
observ
mer
patient
may
suffici
resist
merscov
entri
consist
within
physiolog
rang
fail
induc
signific
reduct
viral
plaqu
plaqueform
assay
use
merscov
fig
previou
studi
suggest
inflamm
tend
increas
level
wronkowitz
et
al
alter
activ
concentr
serum
associ
variou
patholog
condit
klemann
et
al
chronic
infect
hepat
c
e
virus
significantli
increas
activ
protein
level
patient
sera
andrieu
et
al
rafiei
et
al
also
elev
bronchoalveolar
lavag
fluid
patient
pulmonari
patholog
condit
level
regul
independ
serum
level
juilleratjeanneret
et
al
recent
shown
express
pulmonari
tissu
smoker
patient
chronic
respiratori
diseas
upregul
could
partial
explain
individu
suscept
merscov
infect
meyerholz
et
al
sey
et
al
observ
releas
respiratori
secret
mer
patient
vari
degre
although
show
whether
level
respiratori
secret
upregul
suppos
lung
inflamm
induc
merscov
infect
may
upregul
secret
report
pulmonari
diseas
juilleratjeanneret
et
al
howev
interest
note
level
plasma
mer
patient
significantli
lower
normal
volunt
downregul
circul
sera
also
report
variou
inflammatori
diseas
rheumatoid
arthriti
sepsi
sever
cancer
klemann
et
al
even
though
control
sourc
system
shed
poorli
understood
sever
organ
includ
spleen
lung
liver
kidney
immun
cell
high
activ
might
put
target
regul
system
level
plasma
mulvihil
drucker
sinc
larg
number
studi
clearli
demonstr
also
play
integr
role
immun
system
klemann
et
al
would
interest
determin
merscov
infect
regul
express
secret
specif
role
reduc
antivir
immun
viral
pathogenesi
interestingli
assess
variou
cytokin
level
plasma
sampl
previou
studi
level
egf
significantli
neg
posit
correl
plasma
concentr
respect
fig
function
correl
immunesuppress
cytokin
protect
growth
factor
egf
mucos
epithelium
diseas
sever
need
care
assess
futur
studi
larger
sampl
size
nevertheless
physiolog
concentr
suffici
significantli
reduc
merscov
infect
suggest
exogen
may
therapeut
potenti
mer
patient
addit
level
infect
merscov
might
associ
suscept
diseas
sever
sinc
concentr
rel
variabl
among
normal
individu
fig
physiolog
role
merscov
pathogenesi
viral
life
cycl
also
remain
elucid
supplementari
tabl
everi
experi
perform
duplic
p
valu
calcul
student
ttest
oneway
analysi
varianc
p
p
correl
egf
level
patient
plasma
plasma
level
neg
posit
correl
egf
level
respect
concentr
egf
plasma
sampl
n
determin
previou
report
correl
level
cytokin
assess
linear
regress
analysi
red
line
r
p
valu
shown
